$ALMS
Alumis Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
ALMS chart
What traders are saying about $ALMS
Latest postsAlumis Inc. news
- Alumis Inc. Estimates – NASDAQ:ALMS
TradingView ·
- InvestingPro Fair Value flagged Alumis as overvalued before 46% fall By Investing.com
Investing.com ·
- Citigroup Adjusts Price Target on Albemarle to $125 From $175
Yahoo Finance ·
- Alumis snags set of Phase III psoriasis pill victories, but analysts lukewarm on impact
clinicaltrialsarena.com ·
- Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures
Yahoo Finance ·
- Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
Yahoo Finance ·
- Alumis (ALMS) Plans to Advance Envudeucitinib After LUMUS Missed in the Overall Population
Yahoo Finance ·
- Alumis to Participate in Upcoming September Investor Conferences
Yahoo Finance ·
- Is Alumis (ALMS) Overvalued After Its 121% One Year Return?
Yahoo Finance ·
- Why Alumis (ALMS) Is Down 56.2% After Mixed Phase 2b Lupus Data Spotlight Biomarker Strategy
Yahoo Finance ·
- Alumis (ALMS) Looks Pricey After Its Lupus Trial Miss But Is 3x P B Fair?
Yahoo Finance ·
- Alumis (ALMS) Lead Lupus Drug Missed Phase 2b Trial Endpoints
Yahoo Finance ·
Alumis Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $24.1M | – | – |
| Net income | -$243.3M | -$294.2M | -$155.0M |
| Diluted EPS | $-2.86 | $-10.38 | $-72.08 |
| Total assets (year end) | $411.9M | $341.0M | $89.6M |
| Cash and equivalents (year end) | $89.7M | $169.5M | $46.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Alumis Inc.
- Ticker
- ALMS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1847367
- Former names
- FL2021-001, Inc.
Frequently asked questions
What exchange is Alumis Inc. listed on?
Alumis Inc. trades on the Nasdaq under the ticker symbol ALMS.
What industry is Alumis Inc. in?
Alumis Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Alumis Inc. headquartered?
Alumis Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Alumis Inc.'s fiscal year end?
Alumis Inc.'s fiscal year ends on December 31.
How much revenue did Alumis Inc. report?
Alumis Inc. reported $24.1M in revenue for calendar year 2025, according to its SEC filings.